News | Analytics Software | October 31, 2016

Children's Hospital of Philadelphia Recognized for Creating Venous Thromboembolism Recognition Technology

Hospital’s Information Services team created system that uses natural language processing to scan radiologist reports to identify patients potentially at high risk for hospital-acquired VTE

October 31, 2016 — In an effort to improve patient care, Children's Hospital of Philadelphia's (CHOP) Information Services team is using data and advanced analytics to screen patients for venous thromboembolism (VTE). This innovative technology is being honored by Drexel University and CIO.com in their inaugural Analytics 50 award ceremony, which will be held on Nov. 9, 2016 at Drexel University's LeBow College of Business.

VTE is currently the second-most common contributor to harm in hospitalized pediatric patients. If left untreated, it can result in a pulmonary embolism, infection or death. Using natural language processing (NLP), CHOP now scans radiologists' reports for designated keywords and phrases to provide a high level of accuracy in identifying and tracking patients who could be at risk for hospital-acquired VTE.

"Before creating this technology, VTE identification was dependent upon manually-generated clinical lists and post-discharge case reviews, both of which are time-consuming, error-prone and do not provide immediate identification," said John Martin, senior director of enterprise analytics at CHOP. "By using NLP, we automated the process and can identify at-risk patients more quickly, with high sensitivity and specificity."

CHOP was previously recognized nationally as a finalist for a Business Innovator Award in the 2016 InformationWeek Elite 100 ranking.

For more information: www.chop.edu

Related Content

The new transducer reaches a 30% greater penetration, so clinicians have detailed images and performance they need to make a definitive diagnosis for pediatric patients, reducing the need for additional diagnostic imaging steps
News | Pediatric Imaging | May 06, 2020
May 6, 2020 — Philips announced the ...
Whole body diffusion-weighted magnetic resonance imaging (DW MRI) may aid in the assessment of cancer treatment response in children and youth at much lower levels of radiation than current approaches, suggests a small study funded by the National Institutes of Health.
News | Pediatric Imaging | May 05, 2020
May 5, 2020 — Whole body diffusion-weighted magnetic resonance imaging (DW MRI) may aid in the assessment of...
16-year-old girl with coronavirus disease (COVID-19) and known history of tuberous sclerosis who presented with acute hypoxic respiratory distress. Reverse transcription–polymerase chain reaction testing confirmed diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

16-year-old girl with coronavirus disease (COVID-19) and known history of tuberous sclerosis who presented with acute hypoxic respiratory distress. Reverse transcription–polymerase chain reaction testing confirmed diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

A, Frontal chest radiograph obtained at initial presentation shows bilateral lower lung zone–predominant consolidations and, to lesser extent, ground-glass opacities. B, Frontal chest radiograph obtained 2 days after hospital admission shows interval increase in consolidation in bilateral lower lung zones. C, Frontal chest radiograph obtained 6 days after hospital admission and treatment shows interval improvement in consolidations in bilateral lower lung zones.

News | Coronavirus (COVID-19) | May 01, 2020
May 1, 2020 — 
“Everybody cares about radiation dose, but the most sensitive to radiation are children, because they’re growing.”  —Richard Towbin, M.D., Chief of Radiology, Phoenix Children’s Hospital

“Everybody cares about radiation dose, but the most sensitive to radiation are children, because they’re growing.”
—Richard Towbin, M.D., Chief of Radiology, Phoenix Children’s Hospital

Sponsored Content | Case Study | Radiation Dose Management | April 09, 2020
Medical imaging plays an increasing role in the accurate diagnosis and treatment of numerous medical conditions.
AI vendor Infervision's InferRead CT Pneumonia software uses artificial intelligence-assisted diagnosis tp improve the overall efficiency of the radiology department. It is being delayed in China as a high sensitivity detection aid for novel coronavirus pneumonia (COVID-19). #COVID-19 #COVID19 #Coronavirus #2019-nCoV

AI vendor Infervision's InferRead CT Pneumonia software uses artificial intelligence-assisted diagnosis to improve the overall efficiency of the radiology department. It is being developed in China as a high sensitivity detection aid for novel coronavirus pneumonia (COVID-19).

Feature | Coronavirus (COVID-19) | February 28, 2020
February 28, 2020 — New healthcare technologies are being implemented in the fight against the novel coronavirus (COV
 Piedmont Rockdale Hospital
News | Mobile Devices | December 19, 2019
December 19, 2019 — Piedmont Rockdale Hospital (Conyers, Ga.), a healthcare provider with a Level III Neonatal Intens
Schematic diagram of the proposed multichannel deep neural network model analyzing multiscale functional brain connectome for a classification task. rsfMRI = resting-state functional MRI.

Schematic diagram of the proposed multichannel deep neural network model analyzing multiscale functional brain connectome for a classification task. rsfMRI = resting-state functional MRI. Graphic courtesy of the Radiological Society of North America.

News | Artificial Intelligence | December 11, 2019
December 11, 2019 — Deep learning, a type of arti...
CT_Pediatric_Scan_Philips_Vereos_CT_RSNA 2016

Image courtesy of Philips Healthcare

News | Pediatric Imaging | December 10, 2019
December 10, 2019 — More than half of people who received...
Damage from concussion alters the way information is transmitted between the two halves of the brain, according to a new study presented today at the annual meeting of the Radiological Society of North America (RSNA).

Image courtesy of RSNA

News | Clinical Trials | December 10, 2019
December 10, 2019 — Damage from...